Adrien Saliou

1.1k total citations
20 papers, 647 citations indexed

About

Adrien Saliou is a scholar working on Molecular Biology, Virology and Infectious Diseases. According to data from OpenAlex, Adrien Saliou has authored 20 papers receiving a total of 647 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 8 papers in Virology and 7 papers in Infectious Diseases. Recurrent topics in Adrien Saliou's work include HIV Research and Treatment (8 papers), Cancer Genomics and Diagnostics (6 papers) and Genetic factors in colorectal cancer (4 papers). Adrien Saliou is often cited by papers focused on HIV Research and Treatment (8 papers), Cancer Genomics and Diagnostics (6 papers) and Genetic factors in colorectal cancer (4 papers). Adrien Saliou collaborates with scholars based in France, Norway and Italy. Adrien Saliou's co-authors include Marc‐Henri Stern, Olivier Lantz, Jean‐Yves Pierga, François‐Clément Bidard, Jordan Madic, Jacques Izopet, Pierre Delobel, Anne Vincent‐Salomon, Charlotte Proudhon and Charles Decraene and has published in prestigious journals such as PLoS ONE, Scientific Reports and Antimicrobial Agents and Chemotherapy.

In The Last Decade

Adrien Saliou

19 papers receiving 640 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Adrien Saliou France 11 382 227 215 177 146 20 647
Emily Chin United States 12 214 0.6× 227 1.0× 354 1.6× 499 2.8× 87 0.6× 16 724
Gisela Sitbon Sweden 4 185 0.5× 238 1.0× 119 0.6× 99 0.6× 114 0.8× 5 535
Maya Isogai Japan 8 162 0.4× 279 1.2× 181 0.8× 30 0.2× 73 0.5× 11 497
David R. Hout United States 16 112 0.3× 217 1.0× 168 0.8× 97 0.5× 310 2.1× 32 622
JR Gralow United States 9 128 0.3× 230 1.0× 369 1.7× 98 0.6× 37 0.3× 34 796
Kate Poropatich United States 12 47 0.1× 125 0.6× 156 0.7× 156 0.9× 123 0.8× 17 601
Kellie N. Smith United States 15 50 0.1× 206 0.9× 409 1.9× 174 1.0× 67 0.5× 42 756
Jinxia Yao China 7 89 0.2× 118 0.5× 453 2.1× 73 0.4× 176 1.2× 9 1.1k
Leilani Montalvo United States 11 170 0.4× 119 0.5× 88 0.4× 57 0.3× 9 0.1× 14 427
Junji Shibata Japan 10 58 0.2× 96 0.4× 74 0.3× 63 0.4× 190 1.3× 22 577

Countries citing papers authored by Adrien Saliou

Since Specialization
Citations

This map shows the geographic impact of Adrien Saliou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Adrien Saliou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Adrien Saliou more than expected).

Fields of papers citing papers by Adrien Saliou

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Adrien Saliou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Adrien Saliou. The network helps show where Adrien Saliou may publish in the future.

Co-authorship network of co-authors of Adrien Saliou

This figure shows the co-authorship network connecting the top 25 collaborators of Adrien Saliou. A scholar is included among the top collaborators of Adrien Saliou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Adrien Saliou. Adrien Saliou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Chautard, Émilie, et al.. (2024). A single workflow for multi-species blood transcriptomics. BMC Genomics. 25(1). 282–282. 1 indexed citations
3.
4.
Leissner, Philippe, et al.. (2023). Exploring the gut microbiota in patients with pre-diabetes and treatment naïve diabetes type 2 - a pilot study. BMC Endocrine Disorders. 23(1). 179–179. 12 indexed citations
5.
Perret, Magali, Erwin Sentausa, Philippe Leissner, et al.. (2023). Comparison of DNA extraction methods for 16S rRNA gene sequencing in the analysis of the human gut microbiome. Scientific Reports. 13(1). 10279–10279. 22 indexed citations
6.
Mathieu, Alban, et al.. (2020). Draft Genome Sequences of 15 Bacterial Species Constituting the Stable Defined Intestinal Microbiota of the GM15 Gnotobiotic Mouse Model. Microbiology Resource Announcements. 9(35). 3 indexed citations
7.
Decraene, Charles, Amanda Bortolini Silveira, François‐Clément Bidard, et al.. (2017). Multiple Hotspot Mutations Scanning by Single Droplet Digital PCR. Clinical Chemistry. 64(2). 317–328. 43 indexed citations
8.
Riva, Francesca, François‐Clément Bidard, Alexandre Houy, et al.. (2017). Patient-Specific Circulating Tumor DNA Detection during Neoadjuvant Chemotherapy in Triple-Negative Breast Cancer. Clinical Chemistry. 63(3). 691–699. 158 indexed citations
9.
Pierga, Jean‐Yves, Francesca Riva, Alexandre Houy, et al.. (2016). Patient-specific circulating tumor DNA detection during neoadjuvant chemotherapy in triple negative breast cancer. Annals of Oncology. 27. vi79–vi79. 7 indexed citations
10.
Ychou, Marc, Jordan Madic, Adrien Saliou, et al.. (2016). Circulating tumor DNA and circulating tumor cells as predictor of outcome in the PRODIGE14-ACCORD21-METHEP2 phase II trial. Annals of Oncology. 27. vi150–vi150. 5 indexed citations
11.
Jeanne, Nicolas, Adrien Saliou, Romain Carcenac, et al.. (2015). Position-specific automated processing of V3 env ultra-deep pyrosequencing data for predicting HIV-1 tropism. Scientific Reports. 5(1). 16944–16944. 8 indexed citations
12.
Saliou, Adrien, François‐Clément Bidard, Olivier Lantz, et al.. (2015). Circulating tumor DNA for triple-negative breast cancer diagnosis and treatment decisions. Expert Review of Molecular Diagnostics. 16(1). 39–50. 10 indexed citations
13.
Raymond, Stéphanie, Adrien Saliou, Pierre Delobel, et al.. (2014). Evolution of HIV-1 quasispecies and coreceptor use in cell reservoirs of patients on suppressive antiretroviral therapy. Journal of Antimicrobial Chemotherapy. 69(9). 2527–2530. 16 indexed citations
14.
Lebofsky, Ronald, Charles Decraene, Virginie Bernard, et al.. (2014). Circulating tumor DNA as a non‐invasive substitute to metastasis biopsy for tumor genotyping and personalized medicine in a prospective trial across all tumor types. Molecular Oncology. 9(4). 783–790. 216 indexed citations
15.
Raymond, Stéphanie, Adrien Saliou, Florence Nicot, et al.. (2013). Characterization of CXCR4-using HIV-1 during primary infection by ultra-deep pyrosequencing. Journal of Antimicrobial Chemotherapy. 68(12). 2875–2881. 8 indexed citations
16.
Delobel, Pierre, Michelle Cazabat, Adrien Saliou, et al.. (2013). Primary resistance of CCR5-tropic HIV-1 to maraviroc cannot be predicted by the V3 sequence. Journal of Antimicrobial Chemotherapy. 68(11). 2506–2514. 9 indexed citations
17.
Nicot, Florence, Adrien Saliou, Stéphanie Raymond, et al.. (2012). Minority variants associated with resistance to HIV-1 nonnucleoside reverse transcriptase inhibitors during primary infection. Journal of Clinical Virology. 55(2). 107–113. 30 indexed citations
18.
Delobel, Pierre, Adrien Saliou, Florence Nicot, et al.. (2011). Minor HIV-1 Variants with the K103N Resistance Mutation during Intermittent Efavirenz-Containing Antiretroviral Therapy and Virological Failure. PLoS ONE. 6(6). e21655–e21655. 28 indexed citations
19.
Saliou, Adrien, Pierre Delobel, Martine Dubois, et al.. (2011). Concordance between Two Phenotypic Assays and Ultradeep Pyrosequencing for Determining HIV-1 Tropism. Antimicrobial Agents and Chemotherapy. 55(6). 2831–2836. 40 indexed citations
20.
Raymond, Stéphanie, Adrien Saliou, Florence Nicot, et al.. (2011). Frequency of CXCR4-using viruses in primary HIV-1 infections using ultra-deep pyrosequencing. AIDS. 25(13). 1668–1670. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Emily Chin Breakdown of academic impact, for papers by Gisela Sitbon Breakdown of academic impact, for papers by Maya Isogai Breakdown of academic impact, for papers by David R. Hout Breakdown of academic impact, for papers by JR Gralow Breakdown of academic impact, for papers by Kate Poropatich Breakdown of academic impact, for papers by Kellie N. Smith Breakdown of academic impact, for papers by Jinxia Yao Breakdown of academic impact, for papers by Leilani Montalvo Breakdown of academic impact, for papers by Junji Shibata
Rankless by CCL
2026